In August 2011, the FDA published this Drug Safety Communication about adding safety information about Bladder Cancer to the label of drugs containing Pioglitazone. The following drugs contain Pioglitazone: Actos, Actoplus Met, Actoplus Met XR, Duetact. The […]
Read More >>